Antibiotics are standard treatments for fighting dangerous bacterial infections. Yet the number of bacteria developing a resistance to antibiotics is increasing. Researchers from Texas A&M University and the University of São Paulo are overcoming this resistance...
The biotech believes the two Phase 2 trials initiated Thursday can support approval applications for what could be the first so-called allogeneic cancer cell therapy.
A new “fast track” designation allows Lilly to begin the process of seeking approval of tirzepatide for obesity, though the drug will need to succeed in a second trial to get to market.
Researchers from the Center for Plant Biotechnology and Genomics (CBGP, UPM-INIA), in collaboration with the University of Lleida-Agrotecnio and the Catalan Institution for Research and Advanced Studies (ICREA), have succeeded in producing the first transgenic cereals...
The French drugmaker will invest in the biotech and co-promote its drug teplizumab should the FDA clear the medicine as a first-of-its kind diabetes treatment.
